Orchid Pharma Ltd - 524372 - Intimation Of Book Closure For The 27Th Annual General Meeting Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015
Intimation of Book Closure for the 27th Annual General Meeting pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015 Orchid Pharma Ltd - 524372 - Reg. 34 (1) Annual Report
Annual Report for the Financial Year 2019-2020 and Notice of 27th Annual General Meeting Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of newspaper publication dated November 13,2020-Unaudited Standalone and Consolidated financial results for the quarter and half year ended September 30,2020 Orchid Pharma Ltd - 524372 - Unaudited Standalone And Consolidated Financial Results For The Quarter/Half Year Ended September 30,2020
Unaudited Standalone and Consolidated financial results for the quarter/half year ended September 30,2020 Orchid Pharma Ltd - 524372 - Outcome Of Board Meeting Convened On November 11,2020
Outcome of Board meeting convened on November 11,2020 Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Notification As Per Listing Regulations- Notice Of Meeting Of The Board Of Directors-November 11, 2020
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve 1. The Unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30, 2020 2. Fund raising by way of issuance of equity shares through preferential allotment/private placement in single/multiple tranches. Orchid Pharma Ltd - 524372 - Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015
Certificate under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015 Orchid Pharma Ltd - 524372 - Regulation 7(3) Of SEBI (LODR) 2015 - Compliance Certificate For The Half Year Ended September 30, 2020
Regulation 7(3) of SEBI (LODR) 2015 - Compliance certificate for the Half year ended September 30, 2020 Orchid Pharma Ltd - 524372 - Issue Of 14,300 Zero Coupon Unsecured And Non-Marketable Optionally Convertible Debentures Of Rs.1,00,000/- Each Pursuant To Approved Resolution Plan
Issue of 14,300 Zero coupon unsecured and non-marketable Optionally Convertible Debentures of Rs.1,00,000/- each pursuant to approved Resolution plan Orchid Pharma Ltd - 524372 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- NIKITA KDesignation :- Company Secretary and Compliance Officer